PRIO Testbed for molecular phenotype level precision medicine
Reference number | |
Coordinator | Region Stockholm - Proteomik, Patologi |
Funding from Vinnova | SEK 7 014 857 |
Project duration | July 2021 - July 2025 |
Status | Completed |
Venture | Test beds for society´s challenges |
Important results from the project
The project successfully met most of its goals despite challenges. Pilots aligned with the hospital’s strategic priorities had greatest impact and are now planned for clinical implementation. Key achievements include establishment of a PM sample center, the national FOCU.SE trial, a prospective multi-omics workflow, and multiple national and international collaborations. The project also fostered improved workflows, stronger cross-collaboration, and a positive cultural shift within healthcare.
Expected long term effects
The project establishes a test environment that strengthens the development of laboratory methods and processes while enabling cutting-edge research at an international level. It promotes closer integration of research and healthcare, vital for advancing precision diagnostics. By fostering interdisciplinary collaboration, it supports an ecosystem for precision medicine and diagnostics, accelerating the adoption of new methods and enhancing Sweden’s competitiveness in innovative clinical trials.
Approach and implementation
The project began with the establishment of a physical lab within a unit dedicated to research and development. Several pilot initiatives were carried out to update routines and to meet the needs of an observational study—needs that existing services could not effectively address. In addition to developing new and improved research and development services, the project also helped prioritize adjacent initiatives requested by clinical research staff.